Holen Sie sich die Stockscreener-App
8.77
1.68%
-0.15
Handel nachbörslich:
8.76
-0.010
-0.11%
Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten
EBS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Emergent BioSolutions (EBS) SVP reports 116-share tax-withholding disposition - Stock Titan
Emergent BioSolutions (EBS) CFO logs 683-share tax-withholding disposition - Stock Titan
Emergent BioSolutions (EBS) EVP has 313 shares withheld for RSU taxes - Stock Titan
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors - The Globe and Mail
Emergent BioSolutions announces appointment of John D. Fowler, Jr. to board of directors - marketscreener.com
Emergent BioSolutions Adds Independent Director Amid Turnaround Efforts - TipRanks
Emergent BioSolutions appoints John D. Fowler, Jr. as director and Audit and Finance Committee member - TradingView
John Fowler joins Emergent BioSolutions (NYSE: EBS) board, Audit role - Stock Titan
Emergent Biosolutions Announces Appointment Of John D. Fowler, Jr. To Board Of Directors - TradingView
Emergent Biosolutions secures new contracts with Public Health Agency of Canada and Defence Department - Traders Union
Aug Levels: Is Emergent BioSolutions Inc stock showing strong momentumPortfolio Performance Summary & Accurate Intraday Trading Signals - baoquankhu1.vn
Q4 2025 Emergent BioSolutions Inc Earnings Call Transcript - GuruFocus
Emergent BioSolutions Earnings: Revenue, Margins And GAAP Losses Paint Mixed Picture (EBS) - Seeking Alpha
Wall Street Zen Downgrades Emergent Biosolutions (NYSE:EBS) to Buy - MarketBeat
Emergent Biosolutions Q4 Earnings Call Highlights - Yahoo Finance
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Emergent BioSolutions (EBS) Stock Falls on Disappointing Revenue Guidance - GuruFocus
Emergent BioSolutions authorizes $50M stock buyback program By Investing.com - Investing.com India
Why Did Emergent Biosolutions Stock Tumble 20% After-Hours Today? - Stocktwits
Emergent BioSolutions Inc. (EBS): Investor Outlook Reveals 21.62% Potential Upside Amidst Challenging Revenue Growth - DirectorsTalk Interviews
Emergent BioSolutions Stock Pre-Market (-21%): Q4 Revenue Miss & Weak NARCAN Sales - Trefis
Emergent BioSolutions Inc (EBS) Q4 2025 Earnings Call Highlights: Strategic Gains Amid Revenue Challenges - GuruFocus
Emergent BioSolutions Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:EBS) 2026-02-26 - Seeking Alpha
Emergent Biosolutions: Q4 Earnings Snapshot - theheraldreview.com
Earnings call transcript: Emergent Biosolutions Misses Q4 2025 Expectations, Stock Edges Up - Investing.com
Emergent BioSolutions (EBS) Projects Significant Growth in FY26 Earnings - GuruFocus
Emergent BioSolutions (EBS) Eyes Global Expansion and Growth Ini - GuruFocus
Emergent BioSolutions Q4 2025 slides: transformation advances despite revenue miss - Investing.com
Emergent BioSolutions secures $140M contracts with Canada - Investing.com Canada
Emergent BioSolutions Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Emergent BioSolutions (EBS) Secures Major Contracts with Canada - GuruFocus
Emergent BioSolutions (EBS) Reports Q4 Revenue Miss Amid Product - GuruFocus
Emergent BioSolutions (EBS) Approves $50M Stock Repurchase Plan - GuruFocus
Emergent BioSolutions (NYSE: EBS) outlines 2025 turnaround strategy - Stock Titan
Emergent Biosolutions (NYSE:EBS) Releases Quarterly Earnings Results - MarketBeat
Emergent BioSolutions Reports Profitability Amid Ongoing Turnaround - TipRanks
Emergent BioSolutions authorizes $50M stock buyback program - Investing.com
Earnings Summary: Emergent BioSolutions Q4 - Benzinga
Emergent BioSolutions (NYSE: EBS) swings from 2024 loss to 2025 profit - Stock Titan
Tranche Update on Emergent BioSolutions Inc.'s Equity Buyback Plan announced on May 7, 2025. - marketscreener.com
Emergent BioSolutions Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada’s Leadership in Health Preparedness - Yahoo Finance
Emergent BioSolutions Inc (EBS) Q4 2025 Earnings Call Highlights: Strategic Gains Amid Revenue ... By GuruFocus - Investing.com Canada
Emergent Biosolutions: Fourth Quarter Financial Overview - Bitget
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program - Bitget
Three AI Analyst Stocks, LSBK, EBS, and MNSO, Projected to Rise Over 20% - Intellectia AI
How dovish Fed policy supports Emergent BioSolutions Inc. (ER4) stock2025 Trading Volume Trends & Stock Portfolio Risk Management - mfd.ru
Emergent BioSolutions Inc. (EBS) Stock Analysis: Navigating a 22.84% Potential Upside Amidst Healthcare Challenges - DirectorsTalk Interviews
NY Attorney General Brings Action Against Former Emergent BioSolutions CEO - marketscreener.com
Aug Mood: Is Emergent BioSolutions Inc stock showing strong momentumJuly 2025 Price Swings & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Emergent BioSolutions Inc. (EBS) Stock Analysis: A 24% Potential Upside Amid Strategic Healthcare Solutions - DirectorsTalk Interviews
Monday's Underperformers: Auto Dealerships and Biotechnology Shares - Intellectia AI
NY Attorney General brings action against former Emergent BioSolutions CEO - Herbert Smith Freehills Kramer
What's Going On With Emergent BioSolutions Friday?Emergent BioSolutions (NYSE:EBS) - Benzinga
Emergent BioSolutions Says FDA Approves Supplemental NDA for Nasal Spray Product - marketscreener.com
Emergent BioSolutions (EBS) Expands NARCAN Nasal Spray Offering with FDA Approval - GuruFocus
New NARCAN 6- and 24-packs approved to aid large-scale overdose preparedness - Stock Titan
Ebola Virus Therapeutics Pipeline Strengthens with Participation from 18+ Leading Biopharma Companies | DelveInsight - Barchart.com
Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Bitget
Will Emergent BioSolutions Inc. benefit from green energy policiesJuly 2025 Rallies & Low Drawdown Trading Techniques - mfd.ru
Emergent BioSolutions Inc. to Host Conference Call on Q4 and Full Year 2025 Financial Results - Quiver Quantitative
Emergent Biosolutions Inc. $EBS Shares Purchased by Allianz Asset Management GmbH - MarketBeat
Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks - Yahoo Finance
Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN Nasal Spray Multipacks - Bitget
Emergent BioSolutions Receives FDA Approval for New NARCAN® Nasal Spray Multipacks - Intellectia AI
Can Emergent BioSolutions Inc. stock outperform in a bear marketJuly 2025 Review & Low Risk High Reward Trade Ideas - mfd.ru
Emergent BioSolutions (EBS) CFO logs PSU award, share disposition - Stock Titan
0.21%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):